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Abstract
The ability of the perfusion MRI technique, arterial spin labeling (ASL), to quantify cerebral
blood flow (CBF) makes it attractive for longitudinal studies of changes in brain function,
such as those related to chronic pain. However, ASL's poor spatial resolution makes image
alignment between sessions difficult, leading to increased variance and greater Type-I errors.
In addition, variability due to differences in basal blood flow between sessions and
confounding effects such as the arterial transit time (ATT) have the potential to reduce
reproducibility over time. The focus of this thesis is to investigate the ability of ASL to detect
long-term changes in regional CBF within an individual on a voxel-wise level. It is
hypothesized that ASL has the sensitivity to detect activation-induced CBF changes over
periods as long as a month if the sources of variance that degrade between-session
comparisons are minimized. To test this hypothesis rest and activation (motor task) CBF
images were acquired from healthy subjects on three separate imaging sessions. Registration
errors were minimized by using individual head molds to replicate the head position in
successive sessions. Variations in resting CBF were controlled for by performing the imaging
during the same time of day, and subjects were asked to refrain from using common
substances, such as caffeine, that are known to affect CBF. Finally, ATT maps were
generated on each session to investigate its stability. From these data sets, the within- and
between-session variability in CBF was determined and motor-related activation maps were
generated from rest and activation data acquired on from the same session and from sessions
separated by a week and a month. The results demonstrated excellent reliability (intraclass
correlation coefficients greater than 0.75) both within- (0.89 ± 0.2) and between-session
(0.84 ± 0.15), and high reproducibility (within subject coefficient of variation, wsCV, greater
than 20%) within- (wsCV = 4.7 ± 4.5%) and between-session (wsCV = 5.7 ± 4.4%).
Between-session reproducibility of the ATT was high (wsCV = 5.0 ± 2.7%), suggesting that
the confounding effect of ATT over a month was minimal. The similarity in within- and
between-session variability and their activation maps indicated that registration errors
between sessions were minimal. Measures of precision of activation demonstrated that less
than ~20% of between-session activation were false positives. These results demonstrate the
feasibility of conducting voxel-wise analysis of CBF images acquired on different days and
highlight the potential of this technique for longitudinal studies.
ii
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Chapter 1

1

Introduction

1.1 Clinical Relevance: Chronic Pain
In its most benign form, pain is an unpleasant, although necessary short-term sensation
that warns of impending or actual tissue damage. When this sensation outlasts the normal
time of healing, typically identified as 3-6 months, it is considered chronic and no longer
serves a biological purpose

1–3

. Instead, it imposes a burden on the individuals it affects

and society. Chronic pain is one of the most prevalent diseases and is a common cause of
major disability and economic loss 4. One in five Canadians suffer from chronic pain and
each year it costs over $6 billion in healthcare costs and over $37 billion in costs related
to job loss and sick days

4–6

. Compared to other chronic medical conditions, individuals

suffering from chronic pain face significantly lower quality of life as indicated by short
form health surveys (SF-36v2). Upwards of 70% of participants indicated that their
condition greatly interfered with their daily routines 7. Although treatment plans are able
to reduce pain intensity by up to 30%, it does not guarantee an improvement in function 8.
In many cases this means that chronic pain sufferers remain unable to regain their former
independent lifestyles.
Strategies for treatment and management of pain remain a challenge for health care
providers. Since pain is a subjective experience, and in the absence of a biological
marker, the primary tool for assessment is self-reports from patients

9

. While

multidisciplinary treatment approaches that take social and physiological factors into
account help with coping, there is currently an unmet need for novel and efficacious
treatments particularly for individuals with intractable pain who already suffer from acute
diseases such as cancer, HIV and diabetes 6. Treatment of pain has become heavily reliant

2

on opioids for temporary relief which are addictive and have serious side effects. A
recently published review identified that over the past 25 years the steady increase in
dose, volume and prevalence of opioids among chronic pain sufferers and has led to an
overall increase in deaths related to opioid overdoses

10

. Given these unsettling facts,

there is growing need to better understand the underlying causes of chronic pain and
determine potential targets for therapeutic interventions. Functional neuroimaging is a
powerful tool for noninvasively mapping brain activity and has shown promise in pain
research 11.
Perception of acute pain involves the transfer of nerve impulses from the peripheral
nociceptors to the central nervous system and into the brain where these impulses
directed to various regions based on intensity and bodily location of the painful stimulus.
This process has led to the theory that plasticity of the central nervous system plays a role
in the development and maintenance of chronic pain

12

. Unlike the bottom-up state of

acute pain where sensory pain information dominates, chronic pain is believed to be a
top-down state governed by cognitive factors. This was confirmed by neuroimaging
studies which report a strong correlation between alterations in thalamic activity and
duration of chronic pain

13,14

. Long term chronic pain patients had decreased thalamic

activity, suggesting an adaptive top-down response whereas those with early onset of
chronic pain had increased thalamic activity, coinciding with the sensory pathway of pain
processing in healthy individuals.
The vast majority of pain studies have primarily focused on activation related to
stimulated pain

11,15–17

chronic pain state

18,19

. More recently, studies have been investigating the ongoing or

; however, to date no studies have investigated functional changes

in the brain related to progression of acute-to-chronic pain. Being able to quantify these
changes would provide a better understanding of how the duration of pain affects the

3

brain and, more importantly, treatment efficacy. That is, can we discriminate between
treatment responders and non-responders based on differences in brain activity related to
their current pain state? Answering this question will require a functional imaging
method capable of longitudinal monitoring. Ideally the technique would have the
sensitivity to monitor changes in individual patients considering the large variability in
treatment response. Towards this goal, this thesis will focus on investigating a method for
detecting long-term changes in cerebral blood flow.

1.2 Modern Neuroimaging
The predominant brain mapping methods being used currently are based on the coupling
between neuronal activity and regional cerebral blood flow (CBF). These neuroimaging
techniques can be broadly categorized into nuclear medicine and functional magnetic
resonance imaging (fMRI) methods. Nuclear imaging techniques consist of positron
emission tomography (PET) and single photon emission computed tomography (SPECT),
while fMRI encompasses blood oxygen dependent (BOLD) and arterial spin labeling
(ASL) 20.

Figure 1.1: Comparison of general characteristics of nuclear imaging techniques (PET/SPECT),
shown in blue, and functional MRI technique (BOLD), shown in pink. Areas of overlap are
shown in purple.

4

Each approach bears strengths and weaknesses, making them better suited for different
applications (Figure 1.1). Nuclear perfusion imaging techniques involve measuring the
uptake of an injected radioactive tracer. Based on the pharmacokinetics of the tracer,
detected regional activity distribution will reflect various biological parameters. To
measure CBF, PET uses radioactive water (15O-H2O) whereas gamma emitting
hexamethylpropyleneamine oxime technetium (99mTc-HMPAO) is a commonly used
SPECT flow tracer. The utility of PET and SPECT stems from their abilities to detect
nanomoles of tracer with high sensitivity and specificity in absolute units

21

. However,

exposure to ionizing radiation and the half-life of the tracer limits the number of
measurements acquired per subject. This limits voxel-wise analysis, or statistical
parametric mapping (SPM), to either group analysis or a template-based approach

22,23

.

For the purposes of tracking disease progression within a single subject, this approach is
suboptimal because the detected activity depends on the control template and the
accuracy of spatial normalization

24

. For example, in a PET study comparing glucose

metabolism patterns in Alzheimer’s disease patients to healthy controls, the extent and
localization of regions demonstrating metabolic changes varied based on whether a
common
data

25

18

F-FDG PET or

15

O-H2O PET template was used to spatially normalize the

. These artifacts or false positives due to normalization can introduce ambiguities

into the final interpretation of the results. Additionally, modeling tracer kinetics required
for CBF quantification is an involved and invasive process as the time-dependent
variation in the radioactivity in the arterial blood needs to be measured by collecting
arterial blood samples. This is both time consuming and sensitive to error, making it
difficult to justify for routine imaging. To avoid arterial sampling, the arterial input
function can be estimated based a population-based input function

26,27

. However, the

shape of the arterial input will vary based on the disease group and the radioactive tracer
being used, introducing variability in CBF estimations. Alternatively, a semi-quantitative

5

approach may be implemented by intensity normalizing signals to a global mean at the
expense of reduced accuracy 28,29.
FMRI is a more popular technique for functional imaging as it offers a safe and noninvasive approach to measuring brain function. The dominant method using BOLD
contrast is based on the change in the oxyhemoglobin concentration caused by an
increase in CBF

30

. Deoxyhemoglobin is a paramagnetic molecule that produces a

susceptibility induced field change, resulting in a decrease in the apparent transverse
relaxation time constant (T2*) 31,32. Oxyhemoglobin, on the other hand, is diamagnetic 33.
With increased brain activity, the amount of oxyhemoglobin relative to deoxyhemoglobin
increases due to the increase in CBF. This results in a local increase in T2*. While BOLD
has become the standard neuroimaging method, low frequency baseline signal drifts
reduce its sensitivity if the spacing between the baseline and stimulus is greater than a
few minutes 34,35. In addition, BOLD contrast is a relative signal change and consequently
the technique is not suitable for monitoring across imaging sessions 36.
The stability of the ASL signal combined with being non-invasive, unlike PET and
SPECT, and quantifiable, unlike BOLD, makes it ideal for studying long-term changes in
brain activity. The unique feature that separates ASL from the other functional
neuroimaging techniques is that arterial blood water is used as an endogenous diffusible
tracer. Image contrast is based on the changes in brain tissue signal due to the increase or
decrease in tracer concentration. Since subjects are not exposed to ionizing radiation, the
technique is well suited to repeated scanning 37. This is advantageous in populations (e.g.
pediatric or renal disease) where the use of radioactive tracers poses a large risk

38

. In

relation to BOLD, ASL provides greater spatial localization. The spatial correlation of the
BOLD signal to the site of activation is relatively poor since more than 65% of the BOLD
signal is accounted for by intravascular spins 39. In contrast, the ASL signal reflects tracer

6

delivered to the tissue. Consequently, in theory ASL reflects regional changes in activity
with greater sensitivity. Furthermore, since CBF is in theory insensitive to scanning
parameters, in addition to the traditional detection of global hypo and hyperperfusion, it
permits comparison of multiple measurements in a longitudinal study 40.

1.3 Arterial Spin Labeling
1.3.1 Overview
As previously alluded to, ASL signal contrast is generated by magnetically labeling the
blood flowing into the tissue of interest

41

. Following a short delay to allow the labeled

blood water to reach the imaging plane, an image that contains signal from labeled water
and static tissue is acquired. To remove the static tissue contribution, a second image,
known as the control, is acquired using the same imaging parameters, but without the
arterial labeling. Control and tag images are acquired in interleaved succession.
Subtraction of the control-tag pairs results in perfusion weighted or difference images
(ΔM) that are directly proportional to CBF 42.
The magnitude of the signal difference is dependent on the lifetime of the labeled blood
water - i.e., the longitudinal relaxation time of blood, T1a (1300 – 1750 ms); the amount
of time it takes for the labeled blood water to reach imaging voxels, which is referred to
as the arterial transit time (ATT) (800 – 1200 ms); and blood flow 43. Since the ATT and
T1a are similar in magnitude, the signal change is typically only 0.5 - 1% of equilibrium
magnetization, resulting in a poor signal-to-noise ratio (SNR)

38

. To improve the SNR,

ASL images are acquired at relatively low resolution (4 x 4 x 6 mm3 voxel) and multiple
control-tag pairs are acquired for signal averaging

44

. In a study by Gevers et al., it was

estimated that 20 control-tag pairs are required to obtain steady and reproducible CBF
values

45

. Although, to improve the SNR, it is not uncommon to acquire upwards of 40

7

images

38,46

. A second limitation of ASL is its temporal resolution. To obtain a single

perfusion weighted image, two images, namely the control and label, are required. Since
repetition times range between 2 – 4 seconds, perfusion weighted images are acquired
every 4 – 8 seconds

43

. This makes ASL less suitable for detecting fast changes in the

brain. In addition, it can lead to increased sensitivity to gross head motion and
physiological motion 47. With emerging methods such as single-shot ASL, where control
and tag images are acquired after a single labeling period, and phased array receiver coils
which can be optimized for parallel imaging, scan time can be reduced 48.
Clinically, ASL imaging has been used to study conditions including, but not limited to
chronic pain

17,49

, Alzheimer’s disease

50,51

, stroke and carotid occlusive diseases

52,53

. In

addition to its clinical applications, ASL has provided valuable information regarding
physiology in healthy individuals

54,55

and drug development

56–58

. It has been

demonstrated that ASL has the sensitivity to detect relevant changes in CBF within an
individual. For example, in a study assessing activation related to experimental pain, ASL
was able to detect as small as a 2.2% change in CBF within an individual 15. Furthermore,
ASL has been validated against PET perfusion imaging, the gold standard method of
CBF measurement 59–61.

1.3.2 Labeling Schemes
Depending on the duration and spatial extent of signal inversion, labeling strategies are
classified as pulsed (PASL), continuous (CASL) or pseudo-continuous (pCASL) (Figure
1.2). With PASL, a large volume of tissue (10-20 cm) proximal to the imaging slice is
labeled using a short (5 – 25 ms) inversion radiofrequency (RF) pulse 62–64. With CASL,
a continuous off-resonance RF pulse, typically 1 – 3 s, is applied in the presence of weak
gradient to invert the magnetization of arterial blood flowing through a labeling plane
perpendicular to the feeding artery

38,65

. This process is known as adiabatic fast passage

8

(AFP). In the presence of an applied magnetic gradient, the resonant frequency is
spatially dependent and the blood magnetization experiences a frequency sweep as it
flows through the labeling plane. For a high inversion efficiency, denoted α, blood
passing through the plane needs to meet the adiabatic condition: 1/T1, 1/T2 << Gν/B1 <<
γB1 66, where T1 is the longitudinal relaxation rate, T2 is the transverse relaxation rate, G
is the gradient amplitude, ν is the velocity of blood along the direction of the gradient, B1
is the strength of the RF magnetic field and γ is the gyromagnetic constant. The strength
of the applied gradient and RF are chosen based on the typical range of velocities found
in the carotids.

Figure 1.2: Schematic of (A) PASL, (B) CASL and PCASL labeling schemes overlaid on a
sagittal human brain. PASL inversion of blood and tissue signal occurs in the thick band shaded
in red. For CASL/PCASL, inversion takes place as blood passes through the thin red band.

PASL offers high labeling efficiency, since unlike CASL, signal inversion is not sensitive
to the velocity of blood within the labeling volume

44

. However, the SNR for PASL is

less than for CASL because the in-flowing arterial blood is only labeled once and this
magnetization quickly decays with T1a. Despite the improved SNR achieved using

9

CASL, this approach is difficult to implement due to the off-resonance irradiation of
large marcromolecules in the tissue

67

. The magnetization transfer between this bound

pool and tissue water produces an unwanted signal change that is much greater than the
ASL signal and, therefore, must be carefully controlled. One approach is to use a separate
RF coil for labeling, but this is technically more complicated 68.
To address the limitations of CASL, pCASL, the current recommended labeling strategy,
was developed by Alsop et al.

43,69

. Conceptually, this approach is identical to CASL,

except in lieu of a continuous pulse, a series of short RF pulses (1 pulses/ms) are applied
69

. This labeling scheme results in reduced magnetization transfer effects

43,44,69

. Pseudo-

CASL is easily implemented on conventional 1.5/3 T MRI scanners and has been quickly
adopted in the ASL community.

1.3.3 Cerebral Blood Flow Quantification Model
To quantify CBF in standard units of flow (i.e., mL of blood/100g of tissue/min),
perfusion weighted images are incorporated into the general kinetic model. The general
kinetic model describes the kinetics of ΔM as the delivery function c(t), the residue
function or the clearance of labeled blood from the voxel r(t), and the recovery of the
longitudinal magnetization in the tissue m(t)

70

. For pCASL, the delivery function is

given by the piecewise function:
𝟎
𝒄(𝒕) = 𝜶𝒆
{

−𝑨𝑻𝑻
𝑻𝟏𝒂

𝟎

𝟎 < 𝒕 < 𝑨𝑻𝑻
𝑨𝑻𝑻 < 𝒕 < 𝝉 + 𝑨𝑻𝑻

(1.1)

𝝉 + 𝑨𝑻𝑻 ≤ 𝒕

where ATT is the arterial transit time, T1a is the longitudinal relaxation of arterial blood,
α is the labeling efficiency and τ is the labeling duration. As demonstrated in this
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equation, the delivery of label the tissue is dependent on the ATT, which will be
discussed further in the following sections. Following labeling, the labeled magnetization
in tissue decays at:
−𝒕

(1.2)

𝒎(𝒕) = 𝒆𝑻𝟏

where T1 is the longitudinal relaxation of tissue. Assuming single compartment kinetics,
r(t) is given by:
𝒓(𝒕) = 𝒆

−

𝒇𝒕
𝝀

(1.3)

where f is the CBF in mL/100g/min, and λ is the blood-brain partition coefficient of
water (assumed to be 0.9 mL/g). Since arterial blood water diffuses from the blood into
the tissue, λ represents the equilibrium ratio of the water concentration in tissue and
blood. Although, it varies slightly based on tissue type, error encountered by assuming a
single value is less than 10%

43,71

. The difference signal is the convolution of the input

function with the tissue response. Mathematically,
𝜟𝑴 = 𝟐𝑴𝒐 𝒇{𝒄(𝒕) ∗ [𝒓(𝒕)𝒎(𝒕)]}

(1.4)

Assuming instantaneous exchange of labeled water from the microvasculature to the
surrounding tissue, the analytical solution to the convolution or the difference in
magnetization as a function of time is a stepwise function:
𝜟𝑴(𝒕) =

𝟐𝜶𝑴𝟎 𝒇𝑻𝟏𝒂𝒑𝒑 −𝑨𝑻𝑻
𝒆 𝑻𝟏𝒂
𝝀
𝟎
𝟏−𝒆

∙

{

𝒆

𝟎 < 𝒕 < 𝑨𝑻𝑻

−(𝒕−𝑨𝑻𝑻)
𝑻𝟏𝒂𝒑𝒑

−(𝒕−𝑨𝑻𝑻−𝝉)
𝑻𝟏𝒂𝒑𝒑

(𝟏 − 𝒆

𝑨𝑻𝑻 < 𝒕 < 𝝉 + 𝑨𝑻𝑻
−𝝉
𝑻𝟏𝒂𝒑𝒑

)

𝝉 + 𝑨𝑻𝑻 ≤ 𝒕

(1.5)
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where M0 is the equilibrium magnetization of tissue and T1app is called the apparent T1,
and is given by:
𝟏
𝑻𝟏𝒂𝒑𝒑

=

𝟏
𝒇
+
𝑻𝟏𝐭 𝝀

(1.6)

Considering that T1 of grey matter and blood are similar in values and f/λ is quite small,
it is not unreasonable to assume that T1a is approximately equal to T1app. Using this
assumption, CBF can be determined from Equation (1.5). For the condition that the PDL
> ATT, CBF is given by:
𝑷𝑳𝑫

𝒇=

𝜟𝑴𝝀𝒆 𝑻𝟏𝒂
𝟐𝜶𝑴𝟎 𝑻𝟏𝒂 (𝟏 − 𝒆

−(𝝉+𝑷𝑳𝑫)
𝑻𝟏𝒂
)

(1.7)

1.3.4 Confounds to Cerebral Blood Flow Quantification
Equation (1.7) demonstrates that the relationship between ∆M and CBF depends on the
proton density or equilibrium magnetization (M0), T1a, labeling efficiency, and ATT. T1a,
labeling efficiency and ATT can be based on values from the literature; however,
variability between subjects and variations across brain regions in terms of ATT can lead
to errors in the calculated CBF.
The relaxation rate of the tracer depends on its local environment. Consequently, once the
label diffuses from the blood into the tissue, the relaxation rate shifts from the T1 of
blood (T1a) to the T1 of tissue (T1t). The one compartment model assumes that T1a and
T1t are similar. However, if they are not, assigning a one compartment model can lead to
a ~20% overestimation in grey matter perfusion

72

. An alternate approach which avoids

the need for measuring T1t, is to set the acquisition window such that images are acquired
after the label reaches the microvasculature but before the label diffuses into the tissue.
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Since the signal remains intravascular, the single compartment model is able to provide a
robust estimate of CBF 40.
The second confound to measuring CBF is variations in labeling efficiency. The labeling
efficiency refers to the efficiency of the adiabatic inversion of arterial blood water. In
pCASL, α is assumed to be 85% 69. However, due to magnetic field inhomogeneities and
blood velocities outside the optimal range (10 – 60 mL/100g/min), this value may be
lower than this literature value

40,73

. The labeling efficiency can be measured with phase

contrast (PC) MRI. PC is a non-invasive technique for which applies a gradient to induce
a phase shift in moving protons. The signal intensity reflects the direction and speed of
the protons. To estimate the labeling efficiency, PC images of the feeding arteries of the
brain acquired over one cardiac cycle are used to measure the CBF volume (mL/min).
The ratio of the CBF volume measured with PC and the CBF volume measured with ASL
(i.e. cerebral volume from a T1-weighted image and CBF from ASL) gives the labeling
efficiency 40. Since errors in the labeling efficiency calculation is reflected as a systemic
shift in global CBF, for studies assessing changes in CBF, all images will be affected in
the same manner and therefore will not affect the end result. Consequently, in this
situation, measurement of the labeling efficiency is not essential.
A third confound to accurate CBF quantification is the dependency of the ASL signal on
the ATT. The ATT represents the time required for labeled blood water to move from the
labeling plane to an imaging voxel. To reduce the influence on ATT on the M signal,
Alsop et al., introduced the concept of introducing a delay between the end of the
labeling period and the start of image acquisition (i.e. the PLD) to allow all of the labeled
water to reach the imaging volume

74

. The challenge with this approach is selecting the

optimal PLD. That is, if the PLD is too short, CBF will be underestimated as the labeled
blood has not fully reached the imaging plane, whereas long PLDs lead to substantial
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signal loss due to T1 decay. While the choice of PLD can be selected from previous
studies in which the ATT was directly measured, there are variations due to age, gender,
pathology and within different vascular territories in the brain

75

. For example, older

individuals, the age bracket where chronic pain is most prevalent 2, have long ATTs
(~1200 ms) as the vessels in the brain becomes more are tortuous 43. Additionally, within
all individuals, there are increased ATT in white matter, water shed regions or vascular
border zone regions 75.
Given these facts, measurement of the ATT can improve the accuracy of CBF
measurements. The interdependence between the ATT and the ASL signal allows for the
measurement of ATT. As shown in Figure 1.3 and Equation (1.5), the ASL signal is
consists of 3 parts. The first period is the time when the labeled blood has not reached the
imaging voxel and therefore the signal is equal to zero.

Figure 1.3: pCASL fractional signal as a function of time. The plot was generated using Equation
(1.5) and the following parameters: α = 85%, CBF = 60 mL/100g/min, T1a = T1app = 1650 ms,
ATT = 800 ms, λ = 0.9 mL/g and τ = 1500 ms.
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As the inflowing labeled blood water reaches the imaging voxel or tissue, the signal
increases. Finally as the signal decays, the signal decreases. By acquiring ASL images at
multiple PLDs and fitting the fractional signal to Equation (1.5), the ATT can be
estimated. Current strategies proposed for measuring ATT, such as those involving blood
flow crusher gradients or multiple PLDs, tend to be time consuming, suffer from low
SNR and contamination from intravascular signals; thus, leading to inaccurate
measurements 76. A second approach is to use a relatively low resolution ASL sequence.
ATT images are fundamentally low resolution since variations are based on large
vascular territories

76

. By increasing the voxel size, the time required to acquire ATT

images is greatly reduced.

1.4 Reproducibility, Reliability and Precision Measurements
Analysis of measurement error is an important step towards the widespread use of a new
technique. Reliability refers to the magnitude of error variance relative to “true” and
inherent variability between subjects. In other words, it expresses the consistency of test
and retest measurements made at different time points. Reliability is measured using the
intra-class correlation coefficient (ICC) 77. Although there are six versions, the most basic
2
form of the ICC is given by the ratio between the between-subjects (𝜎𝑏𝑠
) variance and the
2
total variance (or the sum of between subject variance and the error variance (𝜎𝑒𝑟
):

𝑰𝑪𝑪 =

𝝈𝟐𝒃𝒔

(1.8)

𝝈𝟐𝒃𝒔 + 𝝈𝟐𝒆𝒓

In a repeated measures design or a two way mixed model design, error variance is
2
considered to come from one of two sources: systematic error (𝜎𝑠𝑒
), or error due to bias
2
in the repeated measures, and random error (𝜎𝑒𝑟
), or error due to chance factors

Taking these into account, the ICC becomes:

77

.
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𝑰𝑪𝑪 =

𝝈𝟐𝒃𝒔

(1.9)

𝝈𝟐𝒃𝒔 + 𝝈𝟐𝒔𝒆 + 𝝈𝟐𝒆𝒓

ICC values vary from 0 to 1 where values closer to 1 represent greater agreement
between measurements. As a general guideline, ICC < 0.4 is denoted as poor, 0.4 – 0.59
as fair, 0.60 – 0.74 as good, and > 0.75 as excellent 78. A notable weakness of using the
ICC as a measure of reliability is that it is dependent on the variability between subjects
in the sample. For example, populations with low between-subject variability will have
artificially deflated ICC values relative to a group with high between subject variability
even if the variability between repeated measures is small

79,80

. Consequently, it is

difficult to generalize results as ICC will vary based on the population. For this reason, it
is beneficial to assess the reproducibility in conjunction with reliability.
Reproducibility is defined as the variation in repeated measures from the same subject
under changing conditions

81

. In the ASL literature, it is common to use the

reproducibility to assess variability in resting blood flow or activation patterns from data
acquired on different days 82,83. If the variation between measurements is low, despite the
changing conditions, the reproducibility will be high. Reproducibility is measured using
the within subject coefficient of variation (wsCV). WsCV is the ratio of the standard
deviation of the difference between repeated CBF measurements to the mean CBF

84

.

Mathematically it is given by:
𝒘𝒔𝑪𝑽 =

𝑺𝑫∆𝑪𝑩𝑭
∙ 𝟏𝟎𝟎
𝑴𝒆𝒂𝒏𝑪𝑩𝑭

(1.10)

where 𝑆𝐷∆𝐶𝐵𝐹 is the standard deviation of the difference in CBF. WsCV ranges from 0 –
100%. As a general guideline, wsCV below 20% are considered to be within the normal
range of ASL studies

85

. One of the advantages of the wsCV is that it is a normalized
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parameter and therefore does not depend on the population being studied. This allows for
comparisons across studies.
Precision, also known as the positive predictive value is a commonly used metric used to
assess the ability of a technique to correctly identify relevant information. The precision
is defined as the ratio of the number of correctly predicted positive cases to the total
number of predicted positive cases. Mathematically precision is given by:
𝑷𝒓𝒆𝒄𝒊𝒔𝒊𝒐𝒏 =

𝑻𝑷
∙ 𝟏𝟎𝟎
𝑻𝑷 + 𝑭𝑷

(1.11)

where TP represents the amount of true positives and FP represents the number of false
positives 86. Precision can be used to quantitatively assess the extent of false positives in
activation maps.

Figure 1.4: Depiction of precision measurement. The region shaded in: pink represents false
negatives, blue represents the false negatives and purple represents true positives.

As shown in Figure 1.4, the precision would be the ratio of the purple region to the total
area of the blue and purple region. Precision ranges from 0 – 100%, where higher values
indicate fewer false positives and thus greater similarity between the detected activation
and the true activation.
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1.5 Longitudinal Studies
Knowledge regarding brain function in healthy and chronic pain patients originates from
cross-sectional functional neuroimaging studies

19,87,88

. In general, data are compared

across groups that differ in the variable of interest, but bear great similarity otherwise.
For example, to assess regions associated with pain, chronic pain patients are compared
to age-matched healthy controls

87

. However, to investigate the plasticity of the brain,

simple comparison of controls against patients is not enough. Convergent evidence from
cross-sectional studies indicates that there are changes in brain activity related to the
duration of the disease process 13,14. In addition, these conclusions represent a nomothetic
generality and can misrepresent processes which occur in a single individual

89,90

. For

these reasons, it would be beneficial to test and confirm these hypotheses with
longitudinal studies. Longitudinal studies present a more direct, idiographic measurement
of process-related changes that recognizes individual differences. The distinguishing
feature of longitudinal studies is that subjects are observed repeatedly allowing for direct
assessment of slow changes in CBF over time. Since each subject serves as their own
control, confounding effects, such as differences in age and gender no longer confound
the results. This allows for studying not only chronic pain, but processes that impede and
affect normal development as well as the progression of other pathologies.

1.5.1 Longitudinal Studies with ASL: Challenges and Previous work
As explored in Section 1.2, primarily attributed to its insensitivity to task frequency, ASL
is arguably the best tool at our disposal for longitudinal neuroimaging of changes in brain
function. In addition to being non-invasive, the quantitative feature of ASL – namely its
ability to measure CBF – makes it well suited for comparing functional data acquired in
separate imaging sessions

34

. This was originally demonstrated by Wang et al., who

compared the ability of BOLD and ASL to detect brain activity generated from
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alternating rest and finger tapping periods that were separated by 0.5, 1, 2.5, 5, 10, 20
minutes, 1 and 24 hours

34

. Shown in Figure 1.5 are the BOLD group t-maps

corresponding to intervals of 30 s and 1 h. These images demonstrated the expected
robustness of the BOLD signal when rest and task are separated by 30 seconds; however,
the activation disappears when the rest and task epochs are acquired in different sessions
separated by 1 hour 91. In contrast, activation was detected by ASL at both time intervals,
including a separation of 24 hours; although the statistical power appears to decrease as
the separation increased, as indicated by the decrease in cluster size.

Figure 1.5: Talairach normalized group activation maps of motor task paradigm when rest and
task were separated 30 s and 1 h with BOLD and perfusion (ASL) imaging. Adapted from Wang
et al.34.

Since noise analysis was not performed in this study, a question that remains is the
sources of variability leading to decreased activation at low task frequency. One possible
explanation is that analysis was performed at a group level. Group analysis has decreased
sensitivity for detecting differences between states due to the high variability between
subjects

92

. There is heavy reliance on the accuracy of the normalization procedure as

spatial mismatch of cortical structures reduces the statistical power. In addition because
of this high variability, similar to cross sectional studies, this analysis represents a
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nomothetic generality, that is, conclusions made from a group study may not apply to
individuals.
A second factor is the inherently low SNR of ASL which impedes its sensitivity. When
comparing data between sessions, due to the additional sources of variance, the statistical
power to detect changes is reduced and therefore the cluster size decreases. Sources of
noise in an ASL images can be characterized by scanner and subject noise

93,94

. Scanner

noise reflects changes in signal related to: (1) fluctuations in signal caused by
temperature dependent motion of electrons (thermal noise) and (2) fluctuations in the
functioning MRI hardware including drift and inhomogeneities in the static magnetic
field (systemic noise). Subject noise is generally defined as variability in the signal
caused by the subject's physiology excluding the neuronal activity of interest 95.
While each of these can reduce the SNR and thus the reproducibility of the signal, certain
features of ASL images mitigate their effects. The signal difference between subsequent
control and label pairs is ~1% due to the T1 relaxation of blood. Multiple repetitions are
acquired and averaged to ensure a sufficient SNR. This averaging also reduces thermal
noise. Systemic noise, in particular drift, is reduced by subtracting control-label pairs

35

.

Hence, much of the scanner related noise is small in magnitude can be removed with
preprocessing steps

96

. Subject noise within a session can have severe effects on

reproducibility of resting CBF. Gross head motion within an imaging session causes
blurring which renders the data unusable. With the use of foam to keep the head in place,
as is convention, sequences with background suppression, as well as motion correction
algorithms and spatial smoothing, this variability can be reduced

43

. Consequently for

within-session data, the predominant source of variability is measurement or scanner
error, which in most cases is small

97

. Therefore, studies have been able to demonstrate

high reproducibility of within-session activation acquired on different days 82,98.
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Variability between sessions on the other hand, is greatly influenced by physiologic
factors and therefore it is important to take steps to reduce its influence

85,99,100

. When

data are compared between days, additional variability due to transient effects (e.g.,
mood, arousal, caffeine, food consumption etc.) and between-session co-registration
errors due to variability in head positioning in the scanner can result. Previous studies
have encouraged subjects to abstain from consuming vasoactive substances and/or scaled
the CBF images (e.g. by whole-brain grey matter perfusion), to remove transient changes
in global CBF 101,102. However, scaling needs to be approached with caution as it has the
potential to remove relevant variability

102

. Between-session co-registration errors are

particularly detrimental in multi-slice acquisitions with gaps between slices. Few studies
have assessed the ability of ASL to detect between-session activation, or activation when
rest and task are from separate imaging sessions.
A number of studies have assessed the reproducibility and reliability of resting ASL data
within time frames ranging from hours

85,97

, weeks

99,103

to months

104

. These studies

demonstrated good reproducibility (wsCV < 20%) of resting perfusion. A common
finding was that shorter scan intervals had less variability 82,99. For example, Floyd et al.
found that the coefficient of variability was 5.8% when rest periods were separated by an
hour and increased to 13% when they were separated by a week

99

. Reproducibility in

resting perfusion measured with ASL has also been shown to be comparable to PET
105,106

. In a study by Heijtel et al., it was shown that the repeatability index of CBF

measurements between modalities (22.9%) was similar to the between-session
repeatability for each modality (i.e. PET (27.6%) and ASL (25.1%)). Since the sources of
noise in PET and ASL are different, agreement supports the idea that detected changes
are related to biological processes

85

. Among the labeling schemes, pCASL has been

shown to have the highest reproducibility

100,102

. This is attributed to its superior SNR

relative to PASL and inversion efficiency relative to CASL. Within mean grey matter, the
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wsCV within-session, after an hour and after a week were: 3.5%, 5.5% and 8.5%
respectively. These figures represent on average a 24% decrease in variability relative to
PASL 46% decrease relative to CASL. More recently, studies have shown good
reproducibility across multiple centres

103

and multiple vendors

107

. While these studies

are a good indication of the applicability of ASL within a clinical setting, all of them
focused on region-of-interest (ROI) analysis. ROI analysis is commonly used for both
longitudinal and cross sectional assessments of brain function. However, voxel-wise
analysis bears greater clinical relevance as regions impacted by the disease may not be
known a priori. In addition, accurate delineation of ROIs is performed manually and thus
is susceptible to variability between operators, requires experienced personnel and is time
consuming 108.
The few studies that have performed voxel-wise noise analysis of resting CBF
demonstrated high correlation between within-session measurements and no significant
differences in resting CBF between sessions

102,109

. While baseline variability is an

important factor in the detection of activation in longitudinal studies, on its own it is not
indicative of the reproducibility of the signal. Inherent noise in both rest and task data
introduces uncertainty in regards to what can be considered true activation. Therefore,
full characterization of the detection limits can only be accomplished by pairing baseline
with task data.
Currently, there are two studies which have conducted a similar line of work. The first
study, demonstrated the ability of ASL to detect activation within an individual against a
group baseline template

110

. Activation was generated by comparing resting perfusion

template created from 25 healthy subjects and activation data from a single subject
performing a motor task. Although, activation obtained using the group template and
standard general linear model (GLM) analysis were comparable, use of a template is
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heavily dependent on the accuracy of the spatial normalization and how well the template
characterizes the data

22,24,92

. Therefore, its utility within the context of longitudinal

studies is limited. In the second study, using a visually cued motor task (finger tapping),
the ability of ASL to detect activation when rest and task were separated by 30 days was
compared to activation data generated from rest and task data acquired within the same
session 111.

Figure 1.6: Individual subject activation maps for motor-visual activation task. Panels to the left
are within-session activation, whereas for panels to the right rest and task are separated by 30
days. Adapted from Borogovac et al.111

Within-session data clearly demonstrated the expected activation in the occipital lobe and
the primary motor cortex and supplementary motor cortex (Figure 1.6, left panel).
However, when rest and task data were separated by 30 days, significant voxels unrelated
to the task were observed (Figure 1.6, right panel). In particular, the magnitude and extent
of activation in the motor regions and occipital lobe have increased and spurious
activation is detected. As previously discussed, between-session variability is dominated
by physiological sources of error. Therefore, it is highly possible that the observed
spurious activation is caused by between-session repositioning errors and the increased
magnitude and extent of activation is related to fluctuations in basal blood flow between
sessions. These sources of error are detrimental for longitudinal studies, as false positive
activation could be misinterpreted as activation related to physiology. By taking these
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sources of variation into account, the aim of my thesis is to investigate whether ASL has
the sensitivity to detect longitudinal changes in CBF within an individual at the voxelwise level.
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Chapter 2

2

Methods

2.1 Study Design
The purpose of this study was to investigate the ability of ASL to detect long-term
changes in brain function through the associated changes in regional CBF. By accounting
for sources of variance that can have a significant impact on longitudinal monitoring, the
aim was to show that ASL has the sensitivity to detect activation-induced changes in
regional CBF over periods extending up to a month despite its relatively poor spatial
resolution (4 x 4 x 6 mm3). Previous studies have demonstrated low variability in resting
CBF and the ability of ASL to detect activation between imaging data acquired on
separate days34,102,109,111. However, most of these studies relied on ROI-based analysis
rather than the voxel-wise as would be performed on data collected in the same imaging
session. This work extends on these studies by investigating voxel-wise reproducibility,
reliability and the precision of activation maps produced when resting data were
separated from task data by periods up to a month.
To assess the ability of ASL to detect longitudinal activation, a simple finger tapping task
was chosen because it is a well-studied paradigm that produces focal and robust
activation in the sensorimotor network112. These characteristics are advantageous for
assessing the quality of activation maps generated from data acquired on separate days
because it is relatively straightforward to distinguish between true activation and false
positives based on the well-defined activation patterns associated with motor tasks. To
replicate a potential longitudinal study design that could be used in a clinical cohort, for
instance to assess treatment response in chronic-pain patients, data were collected in three
imaging sessions separated by a week and a month.
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2.1.1 Activation Paradigm
In each of the three imaging sessions, ASL images were acquired continuously (see
Section 1.3.1 for details) during a 5-min rest period followed by a 5-min period of selfpaced sequential finger tapping (right-hand). Volunteers were instructed to lay still with
their eyes closed during the rest period and not focus on a particular task.

Figure 2.1: Sequence for sequential finger tapping; (1) thumb to index finger, (2) thumb to
middle finger, (3) thumb to ring finger, (4) thumb to little finger, (5) thumb to ring finger, (6)
thumb to ring finger, and (7) restarting the sequence from the beginning.

To start the task period, volunteers were verbally cued to begin briskly tapping the tip of
their thumb to each finger with their right hand in a sequential manner, starting with the
index finger and ending on the little, followed by a repetition of the task in reverse
(Figure 2.1).

Figure 2.2: Schematic of motor task paradigm. During the ASL sequence, volunteers perform a
rest and finger tapping task twice. Each epoch lasted 5:36 min (approximately 6 min). Between
the two runs, the equilibrium image (M0) is acquired.
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This sequence was repeated throughout the task period. The entire rest-task paradigm was
performed twice within each imaging sessions with a short delay (~ 1 min) between runs
(Figure 2.2). Volunteers were monitored from the control room of the MRI suite to
ensure the task was being performed properly.
Dividing the rest and task data into two distinct periods, rather than using a more
traditional block design consisted of shorter epochs (e.g. 30 s), was chosen in order to
combine rest and task CBF data from different imaging sessions. That is, baseline CBF
reproducibility and reliability was assessed: (1) within session by comparing CBF images
from the two rest periods, and (2) between sessions by comparing the rest CBF images
from the first session to its counterpart from the second session (1 week separation) and
the third session (1 month separation). In a similar fashion, activation maps associated
with finger tapping were generated from within-session and between-session analysis.
Within-session activation maps were obtained using rest and task CBF images from the
same run within a session. Between-session maps were generated using the task CBF
images from session 1, and either the rest CBF images from the second (1 week
separation), or the third session (1 month separation). For the between-session analysis,
the task data always remained the same (i.e. from session 1) and, therefore, any
deviations in the activation maps would be caused by either fluctuations in resting CBF
across days or registration errors when aligning images from separate sessions.
Activation data from runs 1 and 2 were concatenated separately; task data from run 1 was
always compared to baseline data from run 1 (and similarly for run 2), to avoid
confounding effects, such decreased attentional processing between runs 82. Provided that
sources of between-session variation, such as repositioning errors are minimal, variability
in baseline CBF should be similar to the within-session variation. Likewise, the between
and within-session activation maps should be similar.
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2.1.2 Arterial Transit Time Imaging
Signal changes caused by variations in ATTs can be a significant confounder to ASL
perfusion measurements. Accurate quantification of CBF when using an ASL protocol
with a single PLD relies on the assumption that the labeled arterial blood water will reach
the imaging slice and exchange with tissue water prior to image acquisition, which may
not always occur. In addition, variations in ATT across days could reduce the
reproducibility of the CBF images. Therefore, a second goal of this study was to acquire
ATT images in each of the three imaging sessions in order to determine the betweensession variability in ATT.
A challenge with measuring ATTs is it requires acquiring ASL images at multiple PLDs,
which can significantly increase the overall acquisition time (up to 25 minutes)
this reason, ATT imaging is not routinely performed

111

69

. For

. One approach for reducing the

imaging time, which was adapted in this study, is to collect ASL images used to map
ATT at a lower spatial resolution since variations in ATTs tend to occur between large
vascular territories 69. Lowering the image resolution (e.g. from 3 x 3 x 5 mm3 to 12 x 12
x 4 mm3) improves voxel-based SNR, thereby reducing the number of acquisitions
required to map ATT.

2.2 Volunteers
The study was approved by University Research Ethics Board and all volunteers provided
written informed consent prior to each session. Seven healthy right-handed volunteers (2
male, 5 female, aged 22.6 ± 1.3 years) participated in the study.
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2.3 Between-Session Variability
Subjects were instructed to get adequate sleep and abstain from consuming coffee and
food for at least 6 hours and alcohol for 24 hours prior to scanning due to their potential
vasomotor effects on CBF

113

. The majority of scans were scheduled in the morning to

minimize the effect of diurnal CBF fluctuations 85.
An immobilizing head mold was used to restrict motion within a session and to reduce
variability in head position between sessions. The polyurethane foaming agent was
formed by the reaction of methylene diphenyl diisocyanate (MDI) with a polyol (Alpha
Cradle, Smithers Medical Products, Inc.). The foaming agent was poured into a bag and
which was placed under the volunteer's head inside the head coil. Anatomical landmarks
(nose and eyebrows) were aligned to location markers on the head coil using the external
laser positioning system (LAP Laser, Lüneburg, Germany). Subjects were required to
remain still while the mold set (approximately 15 minutes). On return visits, each
subject’s individual head mold was reused in order that the position of their head from
the first session could be reproduced at closely as possible.
As a secondary step to further minimize errors due to image misalignments, manual
alignment was performed based on comparing structural MRIs acquired in the first and
subsequent session. First, using a sagittal structural image, the anterior-to-posterior
commissure angle was compared to that measured in the first session and a 0 - 6°
adjustment in the angle of the slice was made to reproduce the same slice positioning.
Second, using the axial structural image, slice positioning in the head to foot direction
was adjusted to match the slice location on the first day by comparing easily identifiable
landmarks (i.e. eyes, skull and acoustic nerves). Typically, the axial slice positioning was
adjusted by 0 - 2.5 mm to improve the alignment relative to the images acquired in the
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first session. Following these adjustments, a second axial structural MRI image was
acquired to confirm the accuracy of the axial positioning.

2.4 Data Acquisition
All imaging was conducted using a Siemens 3 T Biograph mMR scanner equipped with a
32-channel head coil (Siemens Medical Systems, Erlangen, Germany). Imaging sessions
began with a localizer scan, followed by the acquisition of high-resolution sagittal T1weighted magnetization prepared rapid gradient echo (MPRAGE) image (repetition time
(TR)/echo time (TE): 2000/2.98 ms, flip angle: 9°, field of view (FOV): 256 x 256 mm 2,
176 slices, voxel size: 1 mm3 isotropic resolution, scan duration: 3:35 min). This imaging
volume was used for sagittal manual image alignment, spatial normalization of the ASL
images to Montreal Neurological Institute (MNI) co-ordinates and to generate grey and
white matter fractional tissue maps. Axial turbo spin echo (TSE) T2-weighted images
(TR/TE: 6100/106 ms, flip angle: 120°, FOV: 220 x 220 mm2, 31 slices, voxel size: 0.57
x 0.57 x 4 mm3, gap: 0.8 mm, scan duration =2:14 min) were acquired for the previously
described axial manual online image realignment.
ASL images were acquired using single-shot 3D gradient/spin-echo (GRASE) sequence
with the following parameters: TR/TE: 3500/22.76 ms, label duration: 1500 ms, PLD:
1200 ms, FOV: 240 x 240 mm2, 24 axial slices, voxel size = 3.8 x 3.8 x 6 mm3, scan time
= 11:12 min)

114

. A pseudo continuous labeling scheme was applied 90 mm below the

center slice. As described in section 2.1.1, the pCASL sequence was performed twice for
the two finger tapping runs. Each run, a total of 96 control-tag pairs were acquired for the
rest and task period (48 control-tag pairs for each condition). Between the runs, an image
set of the equilibrium magnetization was acquired with the same GRASE sequence:
TR/TE: 5000/22.76 ms, PLD: 4000 ms and scan time: 30s.
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For ATT mapping, ASL images were acquired at five PLDs: 700, 1300, 1900, 2500 and
3100 ms. The other changes to the sequence included 5 control/tag images per PLD,
TR/TE: 6000/18.76 ms, FOV: 500 x 500 mm2, voxel size: 12 x 8 x 6 mm3, and a total
scan time of 5 min.

2.5 Image Processing and Analysis
2.5.1 Perfusion-Weighted Imaging
Data was first converted from Digital Imaging and Communications in Medicine
(DICOM) format to Neuroimaging Informatics Technology Initiative (NIfTI) format.
Images were checked for gross motion: translations greater than 3 mm and rotations
greater than 3º as defined by Wang et al. 115. Image processing was performed with SPM8
(Wellcome Trust Center for Neuroimaging, University College London, UK), FSL
(FMRIB Software Library, Functional Magnetic Resonance Imaging of the Brain Centre,
University of Oxford, Oxford, UK) and MATLAB (2012a, The MathWorks, Natick,
MA). The main pre-processing steps are summarized in Figure 2.3. Raw pCASL and M0
data from all sessions were realigned to the first image using a least squares approach and
a six-parameter rigid body spatial transformation. In this step, the first scan of sessions 2
and 3 were aligned to the first scan of session 1. Next, the remaining scans within each
session were aligned to the newly aligned first scan of the session (individually).
Together, these steps corrected for possible differences in head positioning between
sessions and within-session motion. Raw ASL data were pair-wise subtracted to generate
∆M images. Pairwise subtraction of control and label images was performed using
ASLtbx

115

. T1-weighted images were skull stripped using FSL brain extraction tool

(BET) to improve the co-registration and segmentation process

116

. Skull-stripped T1-

weighted images were then segmented using unified segmentation. This step served two
purposes: First, to generate a grey matter mask used to estimate of grey matter CBF; and
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second, to generate normalization parameters based on morphology of the brain 117. Each
subject’s M0 image was co-registered to their respective skull-stripped high-resolution
T1-weighted image with a rigid body transformation to correct for in-plane shifts and
rotations and to improve the accuracy of the normalization process.

Figure 2.3: Overview of preprocessing steps. Green arrows represent the structural processing
pipeline and red arrows represent perfusion weighted image pipeline. Briefly, (1) images were
motion corrected; (2) ASL images were pairwise subtracted; T1-weighted images were skull
stripped (3a) and segmented into grey matter and white matter (3b); (3) M0 images were coregistered to skull stripped T1-weighted images (from step 3a) and the parameters were applied to
the ∆M images; (4) ∆M and M0 images were smoothed; (5) CBF was calculated and (6) spatially
normalized by applying normalization parameters from the segmentation step.

Transformations were estimated iteratively by minimizing the cost function representing
the sum of squares difference in intensities between the anatomical and functional image.
Parameters required to transform the M0 image were applied to the time series of ∆M
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images. The resulting ∆M images were then smoothed with an isotropic 6 mm full width
at half maximum (FWHM) Gaussian kernel to improve the SNR and eliminate any
remaining anatomical variability. ASL images were converted into physiological units
(mL/100g/min) using a single compartment flow model (Equation (2.1)) 118.
𝝎

𝜟𝑴𝝀𝒆𝑻𝟏𝒂

𝒇=

𝟐𝜶𝑴𝟎 𝑻𝟏𝒂 (𝟏 −

−(𝝉+𝝎)
𝒆 𝑻𝟏𝒂 )

(2.1)

The following assumptions were made: λ = blood/tissue water partition coefficient, 0.9
g/mL

71

; α = labeling efficiency 86%

duration 1.5 s; and T1a = 1.650 s
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; ω = post-labeling delay of 1.2 s; τ = label
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. Deformation parameters generated in the

segmentation step were used to transform CBF maps into MNI space.

2.5.2 Arterial Transit Time Images
All raw ASL data were realigned using the same two-step process as the single PLD ASL
data. Using ASLtbx, control images were subtracted from their labeled pair. The FSL
BET routine was used to skull strip both the T1-weighted and ATT images. A voxel-wise
parametric fit of perfusion-weighted data to the one compartment kinetic model was
performed using the fast ASL and BOLD Bayesian estimation routine (FSL, FABBER)
120

. The Bayesian approach provides more robust estimates of ATT and CBF using prior

knowledge about the parameters (i.e. CBF, ATT, bolus length, T1 of tissue) based on
biophysically realistic assumptions 121. The model included spatial priors and was iterated
200 times to maximize convergence. The resulting estimate of ATT was co-registered to
their respective T1-weighted image volume using a rigid-body transformation in SPM.
Next, skull stripped T1-weighted and ATT images were normalized to the MNI template
using the SPM T1-weighted template.

33

2.6 Reproducibility of Arterial Spin Labeling
2.6.1 Variability in Resting Cerebral Blood Flow
Using a 2 x 3 (2 runs / 3 sessions) voxel-wise repeated measures ANOVA that was
implemented in MATLAB, variance was decomposed into within and between-session
contributions,

which

were

used

to

calculate

reproducibility

and

reliability.

Reproducibility was measured using the wsCV 122 given by:
𝒘𝒔𝑪𝑽 =

𝑺𝑫∆𝑪𝑩𝑭
∙ 𝟏𝟎𝟎
𝑴𝒆𝒂𝒏𝑪𝑩𝑭

(2.2)

where 𝑆𝐷∆𝐶𝐵𝐹 represents the standard deviation of CBF between repeated measurements
(i.e. for within-session, 𝑆𝐷∆𝐶𝐵𝐹 represents the standard deviation between runs, and for
between-session, it represents the standard deviation between sessions). 𝑀𝑒𝑎𝑛𝐶𝐵𝐹 is the
average CBF across all sessions. Reliability was measured using a two way mixed model
ICC of absolute agreement 77. This is given by:
𝑰𝑪𝑪 =

𝝈𝟐𝒃𝒔
𝝈𝟐𝒃𝒔 + 𝝈𝟐𝒔𝒆 + 𝝈𝟐𝒆𝒓

(2.3)

2
2
where 𝜎𝑏𝑠
is the between subject variance, 𝜎𝑠𝑒
is the systemic error (variance between the
2
2
repeated measures), and 𝜎𝑒𝑟
is the error variance. For the within-session ICC, 𝜎𝑠𝑒
2
represents the variability between runs, and for the between-session ICC, 𝜎𝑠𝑒
, represents

the variability between sessions. Reliability and reproducibility were also assessed within
regions of interests (ROIs): two based on tissue type (grey and white matter), the four
major lobes (frontal, parietal, temporal, occipital lobe) and pain regions (anterior
cingulate cortex, amygdala, hippocampus, insular cortex, posterior cingulate cortex,
somatosensory cortex and thalamus). Lobe and pain region ROIs were defined using the
Automated Anatomical Labeling (AAL) atlas within the wfupickatlas toolbox in SPM8.
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Grey and white matter masks were generated by thresholding the corresponding SPM8
probability maps by 80 and 60% respectively. Measurements of reliability and
reproducibility within ROIs were generated by multiplying ICC and wsCV images by
dichotomous masks and averaging the values within the defined region.
A 2 x 3 repeated measures ANOVA was conducted with IBM SPSS Statistics (Version
20.0, IBM Corp, Armonk, NY) to test for differences in resting CBF across sessions and
between lobes and tissue types. To assess the effect of day-to-day variations in baseline
CBF on the reproducibility and reliability of CBF, voxel-wise analysis of resting CBF
was performed using absolute CBF (aCBF) and CBF intensity normalized by mean grey
matter CBF (i.e. relative CBF, rCBF).

2.6.2 Variability in Arterial Transit Time
A group mean ATT map was calculated for each session to visualize regional variability.
Reproducibility of ATT was assessed at the voxel-wise level and within grey matter. For
each voxel, wsCV between subjects and between sessions was calculated using variance
derived from the repeated measures ANOVA implemented in MATLAB. In addition,
using SPM, a contrast comparing ATT across sessions (within-subjects repeated
measures design) was formulated to test for significant voxel-wise differences. Since
ATT patterns across the brain are dependent on which vessel they are being supplied by,
namely the anterior cerebral artery (ACA), middle cerebral artery (MCA) or posterior
cerebral arteries (PCA), reproducibility was assessed within these regions. ROIs of the
vascular territories were defined using the AAL template in wfupickatlas based on
templates established by Tatu et. al

123

. A 1 x 3 (1 run x 3 sessions) repeated measures

ANOVA was used to test for differences in ATT between sessions and between vascular
territories in SPSS.
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2.6.3 Motor Activation
2.6.3.1

Reliability and Reproducibility

Activation maps were generated at the subject level for each contrast. Contrasts were
generated by concatenating task data from the first session with rest data from: (a) the
same session, (b) the second session at 1 week and (c) the third session at 1 month as
shown in Figure 2.4.

Figure 2.4: Schematic describing the formation of activation contrasts based on within-session
data and between-session data (1 week and 1 month). Notice that for each of the contrasts, the
task remains the same, while the rest period changes.

Analyses were performed using aCBF and rCBF data sets. Since normalizing by the grey
matter CBF has no effect on within-session activation (i.e., both rest and task data sets are
scaled by the same intensity), only aCBF activation maps were generated for the withinsession analysis. Thus, a total of 5 contrasts were generated for each subject. The first
image set of each series was removed to as the magnetization was not at equilibrium. It is
important to emphasize that the task data remained the same for all contrasts, while the
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rest data varied based on which imaging session it was obtained. Activation maps were
generated using the standard first level GLM analysis in SPM8. Areas of activation were
identified with the t statistic after correction for multiple comparisons using the family
wise error rate (FWE) (p < .05) and no cluster size threshold.

2.6.3.2

Precision of Motor Task Activation

Precision was used to assess the number of false positives detected within session
compared to when rest and task were separated by either a week or a month. Significant
within-session activation, as detected by GLM analysis, was used as the ground truth. To
avoid bias, activated regions from run 2 data were used as the ground truth for the run 1
analysis and vice versa. In addition, masks were dilated by 3 voxels isotropically to
include additional voxels related to motor activation. Voxels were classified as a TP or
FP based on their state (activated or not activated) relative to ground truth.
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Chapter 3

3

Results

3.1 Study Demographics
Five female and two male right-handed volunteers aged 22.6 ± 1.3 years participated in
the study. Subjects were scanned during 3 sessions separated by a week (7.0 ± 0.5 days)
and a month (28.9 ± 2.5 days). Task data from the first run of the first session for subject
1 was removed from the analysis because the task was not performed correctly. A
summary of scan times for each subject is displayed in Table 3.1. While the majority of
the scans took place in the morning, 5 of 21 scans took place in the afternoon due to
scheduling conflicts.
Table 3.1: Scan times for each subject. Scans taken in the afternoon are shown in bold.
Subject

Session 1

Session 2

Session 3

1

9am

4pm

9am

2

9am

2pm

1pm

3

9am

2pm

9am

4

9am

9am

9am

5

9am

9am

9am

6

1pm

9am

9am

7

7am

8am

9am

3.2 Alignment of Images
Figure 3.1 shows T2-weighted images of a representative subject acquired during three
sessions separated by a week and a month (relative to the first session). No additional
post processing steps were applied to these images. Notice the good alignment of the
images from the second and third session relative to the image from the first session,
despite the separation in time. Within-session motion was characterized in terms of the
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rigid transformation (translation and rotation) between the first image of the first run
relative to the first image of the second run required to align images in the realignment
step. Similarly, between-session motion was defined as the difference in translation
between the first images from the two separate sessions (i.e. the first session and either
the second or third session).

Figure 3.1: T2-weighted images acquired during three imaging sessions. Despite the separation
in time and absence of post processing steps (i.e. realignment), the images are near identical. For
this particular subject, the between-session parameters required to align images were: 0.06 ± 0.02,
1.26 ± 0.62 and 0.43 ± 0.55 mm translations in the x, y, and z direction respectively and 0.36 ±
0.25, 0.09 ± 0.02 and 0.02 ± 0.02º rotations in the pitch roll and yaw direction, respectively.

Averaged rotation (roll, pitch, yaw) and translation (x, y, z) parameters from the
realignment step within- and between-sessions are shown in Table 3.2. Transformations
required to align images within the same session were similar to those when aligning
images from two separate sessions. No significant differences was found between the
within-session and between-session translation parameters; although, the magnitude of
the latter was generally higher.
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Table 3.2: Mean translation and rotation parameters within and between sessions.
Translation (mm)
x

y

Rotation (degrees)
z

pitch

roll

yaw

Within
Session

0.30 ± 0.50 1.48 ± 0.37 0.46 ± 0.66

0.22 ± 0.08 0.14 ± 0.10 0.09 ± 0.08

Between
Sessions

0.45 ± 0.76 0.97 ± 0.19 0.67 ± 0.71

0.36 ± 0.38 0.23 ± 0 26 0.14 ± 0.28

3.3 Analysis of Resting Cerebral Blood Flow
3.3.1 Mean Resting Blood Flow
Figure 3.2 shows group averaged mean resting aCBF maps for each session. Within grey
matter the mean CBF was 55.9 ± 9.05, 58.2 ± 4.9, 56.0 ± 5.8 mL/100g/min for sessions 1,
2 and 3 respectively.

Figure 3.2: MNI normalized group average mean resting CBF in ml/100g/ml for sessions 1, 2
and 3. (N=7)

Using the FWE rate (p < .05), voxel-wise within-subjects repeated measures ANOVA
revealed no significant differences resting absolute or relative CBF across sessions or
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between runs. Table 3.3 summarizes mean CBF across subjects within each ROI for each
session and run. Mean CBF demonstrates consistent flow over time. Differences in CBF
within session (run 1 vs run 2) and between sessions (session 1 vs session 2 vs session 3)
were not significant for any of the ROIs. Since there was no significant main effect of
session on CBF, pairwise comparisons between individual sessions were not assessed.
There was also no significant difference in CBF between the 4 major lobes; however,
white matter CBF was significantly lower than grey matter CBF (p < .05).
Table 3.3: Mean resting CBF (ml/100g/ml) in select ROIs (N = 7). (± standard deviation)
Session 1
ROI
Tissue Class
Grey Matter
White Matter
Lobes
Frontal Lobe
Temporal Lobe
Occipital Lobe
Parietal Lobe
Pain Regions
Anterior Cingulate
Amygdala
Hippocampus
Posterior Cingulate
Somatosensory Cortex
Insular Cortex
Thalamus

Session 2

Session 3

Run 1

Run 2

Run 1

Run 2

Run 1

Run 2

57.0 ± 8.8
45.1 ± 7.6

54.8 ± 9.3
43.7 ± 6.7

59.3 ± 5.0
47.9 ± 2.9

57.0 ± 4.8
45.3 ± 2.6

56.0 ± 5.5
44.8 ± 5.1

55.9 ± 6.1
44.8 ± 4.6

57.2 ± 9.7
57.0 ± 8.5
56.8 ± 9.7
56.5 ± 10.4

54.7 ± 9.6
54.6 ± 8.5
55.6 ± 10.0
54.4 ± 9.6

59.4 ± 5.7
59.5 ± 4.7
59.8 ± 8.2
58.6 ± 5.4

57.4 ± 4.7
56.4 ± 3.9
56.7 ± 6.6
56.2 ± 4.3

56.2 ± 5.5
56.1 ± 5.6
56.6 ± 9.6
55.3 ± 6.5

56.0 ± 5.7
55.7 ± 5.2
56.9 ± 9.0
55.5 ± 6.5

60.4 ± 8.9
42.1 ± 5.3
43.2 ± 5.0
55.0 ± 8.1
52.5 ± 6.6
51.8 ± 9.1
42.7 ± 8.2

57.2 ± 9.9
41.0 ± 5.7
42.1 ± 6.6
52.6 ± 7.0
52.8 ± 5.9
49.7 ± 8.1
46.0 ± 6.0

62.9 ± 5.6
46.1 ± 4.5
46.1 ± 3.9
56.7 ± 4.2
57.8 ± 4.2
54.3 ± 5.5
50.4 ± 3.9

60.3 ± 5.2
43.8 ± 3.9
44.5 ± 3.4
54.9 ± 2.5
53.2 ± 3.1
52.1 ± 4.0
44.8 ± 4.4

59.6 ± 5.3
42.3 ± 3.4
43.3 ± 4.0
54.7 ± 5.1
51.7 ± 5.0
51.2 ± 5.8
40.3 ± 7.3

59.2 ± 6.0
42.8 ± 4.4
44.1 ± 4.3
54.6 ± 5.0
52.3 ± 4.0
51.3 ± 6.2
44.4 ± 7.4

3.3.2 Reproducibility of Resting Blood Flow
WsCV maps assessing variability in resting CBF within- and between-sessions are shown
in Figure 3.3. The histogram represents the frequency distribution of voxel-wise wsCV
values for within and between-session analysis. Results are presented for error analysis of
absolute and relative CBF.
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Figure 3.3: Relative and absolute voxel-wise wsCV maps for: (A) within-session aCBF images
(B) between-sessions aCBF images (C) within-session rCBF images, and (D) between-session
rCBF images. The corresponding histograms to the right display the distributions of voxel-wise
within- and between-sessions wsCV values for both aCBF and rCBF data sets.

All wsCV maps were relatively homogeneous throughout cortical grey matter. The
corresponding mean wsCV values for aCBF were 9.1 ± 5.2% and 10.0 ± 4.9% for the
within-session and between-session analyses. Using the rCBF images, within-session
wsCV reduced to 4.7 ± 4.5% and between-session wsCV reduced to 5.7 ± 4.5%. It is
evident from visual inspection of the wsCV maps that there was a global increase in
wsCV in the aCBF images compared to the rCBF images. This increased variance for
aCBF is reflected by its broader and right-shifted distribution in the histograms for both
the within-session and between-session results, and confirmed by the ROI analysis (Table
3.4). Average wsCV values in the majority of ROIs for both within and between-session
results were higher for aCBF compared to rCBF.
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Table 3.4: Mean voxel-wise wsCV for absolute and relative resting CBF in select ROIs (±
standard deviation).
ROI
Tissue Class
Grey Matter
White Matter
Lobes
Frontal Lobe
Temporal Lobe
Occipital Lobe
Parietal Lobe
Pain Regions
Anterior Cingulate
Amygdala
Hippocampus
Posterior Cingulate
Somatosensory Cortex
Insular Cortex
Thalamus

aCBF wsCV (%)
Within
Between
Session
Session

rCBF wsCV(%)
Within
Between
Session
Session

9.1 ± 5.2
9.8 ± 4.6

10.0 ± 4.9
10.9 ± 4.7

4.7 ± 4.5
4.4 ± 4.0

5.7 ± 4.4
5.6 ± 3.4

9.1 ± 4.1
7.8 ± 4.0
8.7 ± 3.6
11.5 ± 5.5

10.0 ± 4.0
8.1 ± 3.0
8.9 ± 3.6
9.2 ± 3.7

3.6 ± 2.8
4.0 ± 3.0
3.0 ± 2.3
4.9 ± 3.8

5.1 ± 3.1
4.8 ± 2.8
5.1 ± 3.1
4.8 ± 3.6

11.2 ± 2.8
8.6 ± 3.4
8.0 ± 4.8
8.3 ± 5.0
9.2 ± 4.1
8.7 ± 4.1
5.1 ± 3.6

9.8 ± 3.5
15.9 ± 4.3
12.3 ± 4.5
13.6 ± 4.5
10.2 ± 4.2
7.7 ± 2.8
21.7 ± 8.1

3.1 ± 1.8
4.2 ± 5.0
6.9 ± 6.5
5.8 ± 5.7
3.5 ± 2.8
3.5 ± 2.4
13.4 ± 5.5

4.4 ± 2.3
7.8 ± 3.3
6.5 ± 4.1
6.2 ± 4.1
5.4 ± 3.5
5.0 ± 2.4
14.6 ± 7.3

While aCBF and rCBF within most ROIs had good reproducibility (wsCV < 20%),
wsCV was noticeably higher in midbrain regions for the between-session analysis (Figure
3.3 B &D), particularly for the aCBF images. For example, the mean wsCV in the
thalamus was 21.7 ± 8.1% for between-session analysis of aCBF images. This increased
variance was reduced by global normalization – in the thalamus the between-session
wsCV reduced to 14.6% in the rCBF images, but this value is still higher than
corresponding cortical and subcortical regions.
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3.3.3 Reliability of Resting Blood Flow
ICC maps and their corresponding histograms are displayed in Figure 3.4. The histogram
distribution represents the frequencies of voxel-wise ICC values from the within and
between-session analysis. Results are presented for both absolute and relative CBF.

Figure 3.4: Voxel-wise ICC maps within and between sessions calculated using absolute CBF
and CBF scaled by mean grey matter CBF (rCBF). (A) within-session aCBF (B) betweensessions aCBF (C) within-session rCBF and (D) between-session rCBF. Corresponding histogram
displaying frequency of ICC values in voxel-wise maps is displayed to the right.

The ICC maps depict excellent within-session grey matter reliability, with ICC values
consistently above 0.75. This is also shown in the corresponding histograms in Figure
3.4: the distributions of ICC values for within-session reliability, shown in orange and
green, are skewed towards a maximum value of 1. Average within-session grey matter
ICC for the aCBF images was 0.85 ± 0.23 and 0.89 ± 0.20 for the rCBF images. Average
within-session and between-session ICC values for all ROIs are given in Table 3.5.
Similar to the wsCV results, mean voxel-wise ICC values was greater within session
compared to between-sessions and for rCBF images compared to aCBF images. Within
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grey matter, between-session reliability calculated with aCBF was good (0.66 ± 0.19)
while rCBF reliability was excellent (0.84 ± 0.15).
Table 3.5: Mean voxel-wise ICC for absolute and relative resting CBF in select ROIs (± standard
deviation).
ROI
Tissue Class
Grey Matter
White Matter
Lobes
Frontal Lobe
Temporal Lobe
Occipital Lobe
Parietal Lobe
Pain Regions
Anterior Cingulate
Amygdala
Hippocampus
Posterior Cingulate
Somatosensory Cortex
Insular Cortex
Thalamus

aCBF ICC
Within
Between
Session
Session

rCBF ICC
Within
Between
Session
Session

0.85 ± 0.23
0.87 ± 0.17

0.66 ± 0.19
0.69 ± 0.17

0.89 ± 0.20
0.92 ± 0.13

0.84 ± 0.15
0.86 ± 0.12

0.93 ± 0.06
0.91 ± 0.06
0.94 ± 0.05
0.86 ± 0.11

0.71 ± 0.16
0.72 ± 0.12
0.75 ± 0.14
0.54 ± 0.21

0.93 ± 0.07
0.92 ± 0.07
0.93 ± 0.07
0.90 ± 0.1

0.85 ± 0.13
0.85 ± 0.11
0.85 ± 0.12
0.79 ± 0.17

0.90 ± 0.06
0.70 ± 0.27
0.68 ± 0.28
0.78 ± 0.24
0.94 ± 0.06
0.88 ± 0.08
0.44 ± 0.39

0.66 ± 0.14
0.34 ± 0.17
0.45 ± 0.18
0.61 ± 0.2
0.74 ± 0.16
0.55 ± 0.21
0.55 ± 0.21

0.95 ± 0.04
0.72 ± 0.28
0.68 ± 0.32
0.87 ± 0.16
0.91 ± 0.08
0.92 ± 0.07
0.61 ± 0.21

0.84 ± 0.11
0.64 ± 0.19
0.73 ± 0.2
0.83 ± 0.13
0.87 ± 0.09
0.84 ± 0.10
0.68 ± 0.17

3.4 Arterial Transit Time Reproducibility
Mean grey matter ATT values averaged across subjects were 806 ± 45, 801 ± 35, and 796
± 39 ms for sessions 1, 2 and 3, respectively. There were no significant differences
between values. Group mean ATT maps for each of the three sessions are shown in
Figure 3.5. Regional heterogeneity in ATTs was observed, with increased ATT towards
medial posterior and medial frontal regions of the brain.
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Figure 3.5: Group mean ATT maps (in seconds) for each session. (N=7)

The spatial patterns of the ATT maps were consistent across sessions, as demonstrated by
the low between-session voxel-wise wsCV (5.0 ± 2.7%). In a voxel-wise repeated
measures ANOVA (implemented in SPM) testing for differences in ATT between
sessions, no voxels survived the statistical threshold (p < .05, FWE). Variability between
subjects was higher than between-sessions with mean grey matter wsCV equal to 9.7 ±
3.5%. The between-subject maps showed increased variability in the medial regions of
the brain, while cortical grey matter remained relatively homogeneous (Figure 3.5).

Figure 3.6: Between-sessions and between-subjects reproducibility of arterial transit times.

46

Since ATT values can vary based on the feeding artery, variability in ATT across the
three main vascular territories was assessed. Mean ATT was the lowest in the ACA (796
± 3 ms) followed by the PCA (812 ± 8 ms) and lastly, the MCA (817 ± 7 ms). Between
the three sessions, there was no significant difference in the ATT. However, the ATT in
the MCA was significantly higher from the value for the ACA territory (p < .05).

3.5 Reproducibility of Motor Task Activation
Activation patterns generated from rest and task data sets from the same session and
those generated from rest and task data acquired in sessions separated by a week and a
month are shown in Figure 3.7. Results are presented for both aCBF and after
normalizing each session’s data by grey matter CBF (i.e. rCBF). Within-session
activation represents the “best case” scenario since it is not affected by additional noise
caused by repositioning errors and day-to-day variations in basal blood flow.
Since the task data remained the same in all comparisons, the within-session and
between-session activation patterns should appear similar, provided these additional
sources of noise were minimal. Regions in color represent voxels that survived the
statistical threshold after correction for multiple comparisons using the FWE rate (p <
.05). There was good agreement in the spatial pattern of activation generated in withinsession and between-session data, particularly after normalizing the perfusion images to
grey matter CBF. In subjects 1 and 2, the diminished cluster size observed in aCBF
between-session activation data relative to within-session data, is not observed when
rCBF was used to generate activation. Interestingly, activation maps generated using
aCBF for subjects 3 and 6 showed an increase in the size of activation in the motor
regions in the between-sessions analysis compared to the original within-session analysis.
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Figure 3.7: Areas of significant CBF increases associated with finger tapping overlaid on a T1weighted MNI template brain. For each subject, activation maps were generated for: (a) withinsession with aCBF rest and task data, (b) aCBF rest and task data separated by a week, (c) aCBF
rest and task data separated by a month, (d) rCBF rest and task data separated by a week and (e)
rCBF rest and task data separated by a month. Regions in colour represent voxels that survived
the statistical threshold after correction for FWE (p < .05). Data from the first run for subject 1
were excluded from this analysis since the task was not performed correctly.
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Percent signal change within the motor cortex for run 1 and run 2 when rest and task
were within the same session, separated by a week and separated by a month are shown
in Table 3.6. There were no significant differences in the percent signal change within the
primary motor cortex for any of the conditions using either absolute or relative CBF.
However, the variability in the CBF response based on the analysis of the aCBF images
was greater for the between-session analyses compared to the within-session analysis.
This was caused by sizable day-to-day variations in resting CBF in some subjects, as
evident for subject 3 in Figure 3.7. The results of the rCBF data show that this variability
is considerably reduced by global normalization.
Table 3.6: Percent CBF change in the motor cortex during finger tapping averaged across all
subjects. Results are reported separately for the two runs and for the within-session and betweensession analyses
Run 1
Within
Session

Run 2

Between-Sessions
Week

Month

Absolute
∆CBF (%)

24.7 ± 8.6 21.0 ± 14.2 28.0 ± 15.8

Relative
∆CBF (%)

25.8 ± 8.1

25.2 ± 6.8

Within
Session
20.2 ± 8.4

Between-Sessions
Week

Month

14.0 ± 12.8

17.2 ± 8.3

19.7 ± 10.2

19.5 ± 7.8

3.6 Precision of Motor Activation
Individual subject precision estimates based on the analysis of aCBF and rCBF data are
shown in Figure 3.8. Data from the first run for subject 1 was excluded as discussed
previously. Mean precision estimates from the within-session analysis and when the rest
and task runs were separated by a week and by a month were 93.9 ± 11.0, 74.2 ± 31.2,
and 65.0 ± 32.7% for aCBF, respectively, and 94.5 ± 12.1, 84.6 ± 15.0, and 78.5 ± 15.2%
for rCBF, respectively. For the majority of subjects, the precision was higher for the
rCBF analysis, particularly for subjects 3 and 6.
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Figure 3.8: Precision measurements for each subject when rest and task data were from the same
session (black), and when rest and task data were separated by a week (grey) or a month (white).

For both aCBF and rCBF data, there appeared to be a decline in precision as the
separation between rest and task increased; however, this trend was only statistically
significant for the rCBF data.
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Chapter 4

4

Discussion

The primary aim of my thesis was to investigate whether ASL has the sensitivity to detect
longitudinal changes in CBF within an individual. This was achieved by: (1) assessing
the within and between-session variability in resting CBF, (2) determining whether
changes in ATT could confound longitudinal perfusion monitoring, and (3) as a proof of
concept, I investigated the ability of ASL to detect motor activation when rest and task
images were from the same session, and when they were separated by a week and a
month.
Exploratory neuroimaging methods are advantageous for identifying regions of the brain
affected by neurological disease, especially when there is little to no a priori knowledge.
This is in contrast to the more widely used ROI-based analysis, in which average CBF
values in predefined regions are compared. There are two main consequences that arise
from this key difference. First, averaging over neighboring voxels reduces the effect of
artifacts caused by realignment errors. In contrast, precise realignment is imperative for
voxel-wise analysis in order to avoid false positive activation arising from spatial offsets.
Secondly, because CBF is not spatially averaged when performing voxel-wise analysis,
the sensitivity of the approach is diminished by additional noise sources when comparing
images from separate sessions. Therefore, for successful exploratory analysis, it is critical
to understand and manage the sources of noise 124.
Within-session variability primarily comes from noise in the MR signal and subject
motion, while between-session variability also includes physiological noise (i.e.
differences in basal blood flow) and errors introduced by differences in head position
between sessions

99,100,125

. Accurate alignment of images from different sessions is
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challenging with ASL because of the relatively large size of the voxels (~ 4 x 4 x 6 mm3),
which are typically used in order to improve SNR. Consequently slight alignment errors
can lead to regional signal differences when comparing CBF images from separate
sessions, and these can translate into false positive activation in the resulting statistical
parametric map

111

. Evidence of this was shown in Figure 1.6 for a visually cued motor

task paradigm in which false activation is easily identified as activation in brain regions
not associated with the paradigm. For my work, a relatively simple approach was
implemented to mitigate registration errors. A personalized head mold was generated for
each subject, which was used in subsequent imaging sessions to replicate the position of
the head from the first day. The effectiveness of this approach is evident in high-contrast
structural MR images shown in Figure 3.1. Despite the fact that the images from sessions
2 and 3 were acquired one week and one month later, they appear nearly identical to the
image acquired on the first day. This agreement is reflected in the similarity in the
magnitude of the between-session and within-session transformation values (Table 3.2).
The magnitude of the rotation and translation required to align images from the separate
sessions were less than 3 mm and 3º, respectively. These results are a good indication that
alignment errors when comparing functional imagines acquired on between days should
be small, thus minimizing false positives in the activation maps115.
The benefits of minimizing variability in head position were evident by the agreement in
the variability measurements for within- and between-session analyses. Average voxelwise wsCV values for grey matter rCBF were 4.7 ± 4.5% from the within-session
analysis and 5.7 ± 4.4% from the between-session analysis. Similarly, the reliability, as
indicated by the ICC measurements, was excellent for both within-session (0.89 ± 0.20)
and between-session analysis (0.84 ± 0.12). This agreement demonstrates that
minimizing registration errors helped to substantially reduce additional variance when
comparing CBF images from separate sessions. Despite the efforts to minimize
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physiological noise in this study, it still contributed to the between-session variability. In
comparison to wsCV for between-session rCBF analysis, the mean wsCV for aCBF was
75% higher and the corresponding ICC decreased from a rating of excellent (0.84 ± 0.12)
to good (0.66 ± 0.19). This marked reduction in between-session reliability and
reproducibility reflects the increased physiological noise caused by day-to-day variations
in CBF associated with diurnal fluctuations and state of arousal

39–41

. Despite efforts to

reduce these effects, these results highlight the challenges of accounting for all sources of
variability. As a caveat, the within-session wsCV also improved after global
normalization. This was likely caused by changes in wakefulness and breathing pattern
during an imaging session42,43. Previous reproducibility studies have used ROIs to assess
within- and between-session variability of resting CBF. For example, Mezue et al.
demonstrated good between-session (week to month separation) reproducibility of resting
grey matter CBF (wsCV 5.3 – 10.0%)24. Similarly, Wang et al. also showed high
reproducibility with a wsCV of 5.7% in cortical grey matter44. The current study indicates
that similar levels of can also be achieved at the voxel-wise level.
The reproducibility and reliability maps (Figure 3.3 and Figure 3.4) revealed spatial
heterogeneity, particularly for the between-session analysis. The most noticeable feature
was the higher variance in the centre of the head, which corresponds to midbrain regions
such as the thalamus. It has been suggested that increased variability in thalamic activity
is a reflection of variability in arousal

82,130

. Mezue et al. demonstrated that resting CBF

in the thalamus decreased over 30 minutes, suggesting a decrease in attentional
processing over time. However in the current study, it is unlikely that thalamic activity is
the sole contributor to the increased variability as the area extends beyond its borders. A
second, possibility is additional noise caused by geometric distortions in the images due
to magnetic susceptibility artifacts in the intracranial cavities near the midbrain

130

.A

third possibility, and the most likely in this study, is related to the 3D GRASE sequence.
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Single-shot 3D imaging was implemented to provide fast acquisition with good spatial
coverage, and SNR, which is advantageous for functional applications

114,131

. However,

since raw image data were acquired within a single excitation with a long acquisition
window due to T2 decay, it is prone to axial signal wrap-around and through-plane
blurring 43,132,133. The greater between-session variance observed in the centre of the head,
resulting from z-direction blurring caused by pulsatile flow in large cerebral vessels
located below the thalamus, could affect the results in applications of interest relating to
midbrain regions. For example, chronic pain, where the thalamus plays a key role in the
modulation of nociceptive information

13,14

. One possible solution would be to use a

multi-shot 3D GRASE sequence to improve the phase encoding along the axial direction
and reduce the acquisition window 132,133.
Recent studies have identified spatial heterogeneity in ATTs as a confounder for
measuring CBF accurately

111,134

. Although multi-PLD sequences have been used to

image ATT and CBF simultaneously, the trade-off is suboptimal SNR for perfusion
imaging and lengthy acquisitions 76. In the current study, a low-resolution ATT sequence
was implemented because ATT values differ based on large vascular territories

109,134,135

.

The similarity in the appearance of group-wise ATT maps generated per session (Figure
3.5) and low between-sessions wsCV values (Figure 3.6) demonstrate that regional ATT
values were consistent across time. In a repeated measures ANOVA that tested for
differences across sessions, no voxels survived statistical threshold (p < .05, FWE).
Likewise the between-session variability was low (wsCV < 10%). Average ATT values
for the three sessions (806 ± 45, 801 ± 35, and 796 ± 39 ms, respectively) were shorter
than the implemented PLD (1.2 s). This indicates that there was sufficient time for
labeled blood water to reach the imaging voxels prior to image acquisition. These results
indicate that the ATT would not be a substantial confound in longitudinal CBF studies, at
least in healthy individuals, provided the chosen PLD is within an optimal range. It would
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be prudent to monitor ATT in longitudinal studies involving older subjects or patients
with vascular disease, considering that low-resolution ATT images can be acquired
within a few minutes 76.
The similarity in the with-session and between-session measures of reproducibility and
reliability indicate that ASL should have sufficient statistical power to detect longitudinal
changes in regional CBF. To demonstrate this, statistical parametric mapping was
performed on rest and motor activation ASL data sets from sessions separated by up to a
month. This approach represents a proof of concept of the ability of ASL to detect low
frequency activation, rather than the variability in activation measured across imaging
sessions, which has been extensively studied

54,82,98,136

. From the within-session analysis,

activation was detected in the primary motor cortex in all subjects and also in the
supplementary motor cortex and the cerebellum in a few subjects (Figure 3.7). The
similarities between these activation maps (i.e. the ground truth) and the corresponding
maps generated using resting CBF data acquired one week and one month later
demonstrate the ability of ASL to detect on a voxel-wise basis longitudinal changes in
CBF. Visual inspection of the within and between-session activation maps generated
before (aCBF) and after global normalization (rCBF) indicate that fluctuations in global
CBF can significantly degrade the activation maps. This effect was most clearly
illustrated in the 1 month aCBF activation map from subject 3. The large number of
falsely identified activated voxels was caused by a 12.4 ml/100g/min change (or 26 %
increase) in global CBF between the two imaging sessions. True activation in motorrelated regions can still be identified by their larger t-scores relative to the values for the
remainder of the brain. Normalizing the CBF images in each session by their
corresponding global value substantially reduced the number of false positives (Figure
3.8), consequently the between-session rCBF activation maps appeared very similar to
the original within-session activation maps (Figure 3.7).
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Despite the remarkable similarities in the appearance of the within and between-session
rCBF activation maps, displaying a single slice cannot properly assess the extent of false
activation. Instead, the quality of the activation maps was characterized by measuring the
precision, which was calculated from the number of true activation voxels in motorrelated regions and the number of false activation voxels in the rest of the brain. Although
this is a relative measure that depends on the extent of brain activation for the chosen
task, it does provide a means of assessing the magnitude of false activation. Similar to the
noise metrics, the precision was found to be lower for the between-session analysis
compared to the within-session, and was better for the rCBF images compared to the
aCBF images. Relative to the within-session activation, the precision decreased by 20%
for aCBF images separated by a week and 30% for aCBF images separated by a month.
As expected, global normalization improved the between-session precision. Relative to
the within-session activation, the precision decreased by 10% for rCBF images separated
by a week and 17% for rCBF images separated by a month. In other words, even with a
month separation between rest and task, less than ~20% of activation detected would be
false positives. Considering that the fraction of true activated voxels was 1% of the total
number of grey matter voxels, these precision estimates highlight the ability of ASL to
detect longitudinal changes in CBF, particularly if the confounding effects of variations
in global CBF are removed.
The minimal CBF change in a given voxel that can be detected was calculated based on
the standard paired samples t-test equation (i.e. ∆CBFmin = (SD∆CBF /√n)/tcrit ). The critical
t-statistic (tcrit) was estimated using the FWE corrected t-threshold generated by voxelwise analysis, SD∆CBF was calculated from the MATLAB implemented ANOVA and n is
the number of perfusion images per run. For the within-session analysis, this threshold
was approximately 3%, while for the between-session analysis it was 7% based on the
variance measured for aCBF and 4% for rCBF. These thresholds are considerably smaller
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than the 20 to 25% change in CBF measured in the motor cortex (Table 3.6), but are inline with previous calculations

15

. The magnitude of the between-session thresholds

indicate that ASL should be capable of detecting longitudinal changes in brain function,
such as caused by pain137, which are associated with smaller CBF changes than those
produced by a sensory task like finger tapping.
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Chapter 5

5

Summary

5.1 Limitations and Future Work
These experiments represent an idealized situation; firstly, the subjects were young and
healthy and secondly, a task paradigm with a predicable activation pattern and large
effect size was used. Detection of regional changes in brain activity in clinical
populations would pose a greater challenge considering there could be greater variability
in the extent and magnitude of changes in regional CBF. Therefore there are a number of
important implications to consider if a similar approach was used in a clinical population.
In this study ATTs were not found to have a substantial effect on the reproducibility of
CBF. However, in older individuals and stroke patients this may not be the case. Studies
have shown that cerebral vessels in older people are more tortuous and therefore the
amount of time it takes for the label to reach the brain increases with age 43. Furthermore,
it could vary over time in patients with age and extent of vascular disease. Future studies
involving older populations or patient populations are likely necessary to verify the
suitability of ASL imaging with one PLD and to assess the stability of the ATTs over
time.
The results of these experiments highlight the benefits of normalizing the CBF image by
the global average; however, this approach should be implemented with caution.
Normalizing in the presence of global systemic shifts between populations has been
shown to alter group-wise differences

126

. It is unclear if normalization on an individual

basis, such as performed in this study, would be affected in a similar manner the same
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issues; however, one solution is to normalize the CBF images by a region considered
unaffected by the disease 101.
Despite high degree of alignment between sessions, the steps employed to reproduce the
same head position across sessions were time consuming, adding on average an extra 30
minutes to the session. This is clearly suboptimal, particularly when dealing with patients
who are less tolerant to long scan times (e.g., children, dementia patients)

138

.

Realignment of the same imaging position in subsequent sessions requires the use of
automatic alignment software. A recent multi-center study highlighted the capability of
using such software to reposition subjects regardless of scanner location and operator 103.
Despite the involvement of 284 subjects and 28 centers, variability baseline CBF was low
(the within-subject standard deviation was 5.3 ml/100g/min). For within session motion,
self-navigation or prospective motion correction techniques (e.g. PROMO) where the
pulse sequence is adjusted in real time based positioning of subject in scanner have
shown promise. However, many of these are sequence specific. In some cases, they
require additional hardware and are often implemented at the expense of increased scan
time 139–141.
Future considerations will be to implement a multi-shot 3D GRASE sequence to avoid
smearing and wrap around effects. This is important for the study of chronic pain
considering a number of midbrain regions are associated with pain perception and this is
the area that demonstrated the highest between-session variability. In these experiments a
relatively simple functional task with a well-defined pattern of activation was used as a
proof of concept. Future experiments could involve a paradigm more closely related to
the disease of interest such as an experimental pain stimulus. Another possibility would
be to increase the time between rest and task sessions given that CBF monitoring over
periods greater than a month would be needed to study disease progression or treatment
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effects. For example, recovery of motor abilities in stroke patients extends beyond 30
days 142.

5.2 Conclusion
This study demonstrated that ASL has the sensitivity to detect motor activation over
periods extending up to a month within an individual. At the voxel-wise level, we
demonstrate low variability in resting CBF, similar within- and between-session
activation, and between-session precision of activation once the effects of basal blood
flow were accounted for. In the young healthy population studied, ATT is not a
substantial confound to the reproducibility of CBF measurements. Future investigations
are required to assess the influence of ATT on the variability of CBF in clinical and older
populations. These results demonstrate the feasibility of conducting voxel-wise analysis
of CBF images acquired on different days and highlights the potential of this technique
for voxel-wise longitudinal studies to assess changes in perfusion related to disease
processes.
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